Volume 238, Issue 5 | Psychopharmacology

Search all Psychopharmacology articles

Volume 238, Issue 5

May 2021

Special Issue on Imaging for CNS drug development and biomarkers

Issue Editor:

Mitul A. Mehta

15 articles in this issue

Challenges in CNS drug development and the role of imaging
Oliver D. Howes
Mitul A. Mehta
Editorial 16 April 2021 Pages: 1229 - 1230
Computational approaches and machine learning for individual-level treatment predictions
Martin P. Paulus
Wesley K. Thompson
Review 27 May 2019 Pages: 1231 - 1239
The potential of ¹H-MRS in CNS drug development
Alice Egerton
Review Open access 05 September 2019 Pages: 1241 - 1254
Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption
Pradeep J. Nathan
Geor Bakker
Review 04 January 2020 Pages: 1255 - 1263
Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment
Beata R. Godlewska
Catherine J. Harmer
Review Open access 15 January 2020 Pages: 1265 - 1278
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients
James Gilleen
Yakub Farah
Sukhi S. Shergill
Original Investigation Open access 08 December 2018 Pages: 1279 - 1289
Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals
Warren B. Logge
Richard W. Morris
Kirsten C. Morley
Original Investigation 20 February 2019 Pages: 1291 - 1302
Choline elevation in amygdala region at recovery indicates longer survival without depressive episode: a magnetic resonance spectroscopy study
Neven Henigsberg
Aleksandar Savić
Petra Kalember
Original Investigation Open access 04 September 2019 Pages: 1303 - 1314
Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use
Grace Blest-Hopley
Aisling O’Neill
Sagnik Bhattacharyya
Original Investigation Open access 09 December 2019 Pages: 1315 - 1331
No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers
Oliver Grimm
Magdalena Nägele
Andreas Reif
Original Investigation Open access 02 November 2020 Pages: 1333 - 1342
Evaluation of dopamine D₃ receptor occupancy by blonanserin using [¹¹C]-(+)-PHNO in schizophrenia patients
Takeshi Sakayori
Amane Tateno
Yoshiro Okubo
Original Investigation Open access 12 November 2020 Pages: 1343 - 1350
Altered fronto-occipital connectivity during visual selective attention in regular cannabis users
Abril Rangel-Pacheco
Brandon J. Lew
Tony W. Wilson
Original Investigation 25 November 2020 Pages: 1351 - 1361
Smoking-related cue reactivity in a virtual reality setting: association between craving and EEG measures
Stefano Tamburin
Denise Dal Lago
Cristiano Chiamulera
Original Investigation Open access 02 December 2020 Pages: 1363 - 1371
Alprazolam-induced EEG spectral power changes in rhesus monkeys: a translational model for the evaluation of the behavioral effects of benzodiazepines
Lais F. Berro
John S. Overton
James K. Rowlett
Original Investigation 16 February 2021 Pages: 1373 - 1386
Association between functional brain alterations and neuropsychological scales in male chronic smokers using resting-state fMRI
Jun-Cheng Weng
Shih-Yu Huang
Ming-Chou Ho
Original Investigation 27 March 2021 Pages: 1387 - 1399